Cargando…
Clofilium inhibits Slick and Slack potassium channels
Slick and Slack high-conductance potassium channels have been recently discovered, and are found in the central nervous system and in the heart. Both channels are activated by Na(+) and Cl(−), and Slick channels are also inhibited by adenosine triphospate (ATP). An important role of setting the rest...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3526865/ https://www.ncbi.nlm.nih.gov/pubmed/23271893 http://dx.doi.org/10.2147/BTT.S33827 |
_version_ | 1782253632259883008 |
---|---|
author | de los Angeles Tejada, Maria Stolpe, Kathleen Meinild, Anne-Kristine Klaerke, Dan A |
author_facet | de los Angeles Tejada, Maria Stolpe, Kathleen Meinild, Anne-Kristine Klaerke, Dan A |
author_sort | de los Angeles Tejada, Maria |
collection | PubMed |
description | Slick and Slack high-conductance potassium channels have been recently discovered, and are found in the central nervous system and in the heart. Both channels are activated by Na(+) and Cl(−), and Slick channels are also inhibited by adenosine triphospate (ATP). An important role of setting the resting membrane potential and controlling the basal excitability of neurons has been suggested for these channels. In addition, no specific blockers for these channels are known up to the present. With the purpose of studying the pharmacological characteristics of Slick and Slack channels, the effects of exposure to the antiarrhythmic compound clofilium were evaluated. Clofilium was able to modulate the activity of Slick and Slack channels effectively, with a stronger effect on Slack than Slick channels. In order to evaluate the pharmacological behavior of Slick and Slack channels further, 38 commonly used potassium channel blockers were tested. Screening of these compounds did not reveal any modulators of Slick and Slack channels, except for clofilium. The present study provides a first approach towards elucidating the pharmacological characteristics of Slick and Slack channels and could be the basis for future studies aimed at developing potent and specific blockers and activators for these channels. |
format | Online Article Text |
id | pubmed-3526865 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-35268652012-12-27 Clofilium inhibits Slick and Slack potassium channels de los Angeles Tejada, Maria Stolpe, Kathleen Meinild, Anne-Kristine Klaerke, Dan A Biologics Original Research Slick and Slack high-conductance potassium channels have been recently discovered, and are found in the central nervous system and in the heart. Both channels are activated by Na(+) and Cl(−), and Slick channels are also inhibited by adenosine triphospate (ATP). An important role of setting the resting membrane potential and controlling the basal excitability of neurons has been suggested for these channels. In addition, no specific blockers for these channels are known up to the present. With the purpose of studying the pharmacological characteristics of Slick and Slack channels, the effects of exposure to the antiarrhythmic compound clofilium were evaluated. Clofilium was able to modulate the activity of Slick and Slack channels effectively, with a stronger effect on Slack than Slick channels. In order to evaluate the pharmacological behavior of Slick and Slack channels further, 38 commonly used potassium channel blockers were tested. Screening of these compounds did not reveal any modulators of Slick and Slack channels, except for clofilium. The present study provides a first approach towards elucidating the pharmacological characteristics of Slick and Slack channels and could be the basis for future studies aimed at developing potent and specific blockers and activators for these channels. Dove Medical Press 2012 2012-12-12 /pmc/articles/PMC3526865/ /pubmed/23271893 http://dx.doi.org/10.2147/BTT.S33827 Text en © 2012 Tejada et al, publisher and licensee Dove Medical Press Ltd. This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited. |
spellingShingle | Original Research de los Angeles Tejada, Maria Stolpe, Kathleen Meinild, Anne-Kristine Klaerke, Dan A Clofilium inhibits Slick and Slack potassium channels |
title | Clofilium inhibits Slick and Slack potassium channels |
title_full | Clofilium inhibits Slick and Slack potassium channels |
title_fullStr | Clofilium inhibits Slick and Slack potassium channels |
title_full_unstemmed | Clofilium inhibits Slick and Slack potassium channels |
title_short | Clofilium inhibits Slick and Slack potassium channels |
title_sort | clofilium inhibits slick and slack potassium channels |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3526865/ https://www.ncbi.nlm.nih.gov/pubmed/23271893 http://dx.doi.org/10.2147/BTT.S33827 |
work_keys_str_mv | AT delosangelestejadamaria clofiliuminhibitsslickandslackpotassiumchannels AT stolpekathleen clofiliuminhibitsslickandslackpotassiumchannels AT meinildannekristine clofiliuminhibitsslickandslackpotassiumchannels AT klaerkedana clofiliuminhibitsslickandslackpotassiumchannels |